136 related articles for article (PubMed ID: 2862952)
1. Somatostatin-like immunoreactivity within neuritic plaques.
Armstrong DM; LeRoy S; Shields D; Terry RD
Brain Res; 1985 Jul; 338(1):71-9. PubMed ID: 2862952
[TBL] [Abstract][Full Text] [Related]
2. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
[TBL] [Abstract][Full Text] [Related]
4. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
[TBL] [Abstract][Full Text] [Related]
5. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
Davies P; Katzman R; Terry RD
Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
[TBL] [Abstract][Full Text] [Related]
6. Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia.
Chan-Palay V; Lang W; Allen YS; Haesler U; Polak JM
J Comp Neurol; 1985 Aug; 238(4):390-400. PubMed ID: 2413088
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease.
Dawbarn D; Emson PC
Biochem Biophys Res Commun; 1985 Jan; 126(1):289-94. PubMed ID: 3838246
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients.
Morrison JH; Rogers J; Scherr S; Benoit R; Bloom FE
Nature; 1985 Mar 7-13; 314(6006):90-2. PubMed ID: 2858056
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin immunoreactive neurons in the human hippocampus and cortex shown by immunogold/silver intensification on vibratome sections: coexistence with neuropeptide Y neurons, and effects in Alzheimer-type dementia.
Chan-Palay V
J Comp Neurol; 1987 Jun; 260(2):201-23. PubMed ID: 2886516
[TBL] [Abstract][Full Text] [Related]
10. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
Crystal HA; Davies P
J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
[TBL] [Abstract][Full Text] [Related]
11. Substance P and somatostatin coexist within neuritic plaques: implications for the pathogenesis of Alzheimer's disease.
Armstrong DM; Benzing WC; Evans J; Terry RD; Shields D; Hansen LA
Neuroscience; 1989; 31(3):663-71. PubMed ID: 2480552
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin- and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type.
Nakamura S; Vincent SR
Brain Res; 1986 Apr; 370(1):11-20. PubMed ID: 2871890
[TBL] [Abstract][Full Text] [Related]
13. APP with Kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimer's disease and non-demented aged subjects: a multifactorial analysis.
Zhan SS; Sandbrink R; Beyreuther K; Schmitt HP
Clin Neuropathol; 1995; 14(3):142-9. PubMed ID: 7671455
[TBL] [Abstract][Full Text] [Related]
14. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
[TBL] [Abstract][Full Text] [Related]
15. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
Papasozomenos SC
Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
[TBL] [Abstract][Full Text] [Related]
16. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain.
Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ
Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760
[TBL] [Abstract][Full Text] [Related]
17. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
[TBL] [Abstract][Full Text] [Related]
18. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of acetylcholinesterase and somatostatin-immunoreactivity in neurons cultured from rat cerebrum.
Delfs JR; Zhu CH; Dichter MA
Science; 1984 Jan; 223(4631):61-3. PubMed ID: 6140757
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptides and neuropathology in the amygdala in Alzheimer's disease: relationship between somatostatin, neuropeptide Y and subregional distribution of neuritic plaques.
Unger JW; McNeill TH; Lapham LL; Hamill RW
Brain Res; 1988 Jun; 452(1-2):293-302. PubMed ID: 2900051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
